Biodegradable nanoparticles for subcutaneous administration of growth hormone releasing factor (hGRF)
- 31 May 1992
- journal article
- Published by Elsevier BV in Journal of Controlled Release
- Vol. 20 (1), 67-77
- https://doi.org/10.1016/0168-3659(92)90140-m
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Nanoparticles as carriers for growth hormone releasing factorJournal of Controlled Release, 1991
- Nanocapsules as carriers for oral peptide deliveryJournal of Controlled Release, 1990
- Pulsatile Versus Continuous Intravenous Administration of Growth Hormone (GH) in GH-Deficient Patients: Effects on Circulating Insulin-Like Growth Factor-I and Metabolic IndicesJournal of Clinical Endocrinology & Metabolism, 1990
- Systemic delivery of therapeutic peptides and proteinsInternational Journal of Pharmaceutics, 1988
- New approach for oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carrierDiabetes, 1988
- Degradation of poly (isobutyl cyanoacrylate) nanoparticlesBiomaterials, 1984
- Pharmacokinetics and distribution of a biodegradable drug-carrierInternational Journal of Pharmaceutics, 1983
- Somatocrinin, growth hormone releasing factor, stimulates secretion of growth hormone in anesthetized ratsBiochemical and Biophysical Research Communications, 1982
- HYPOGLYCqMIC EFFECT OF LIPOSOME-ENTRAPPED INSULIN ADMINISTERED INTRAGASTRICALLY INTO RATSThe Lancet, 1976